Given that head and neck squamous cell carcinoma is often characterized by aberrant activation of YAP/TAZ, NDR1/2 kinases may also have significant regulatory roles in this tumor type, where their dysregulation could disrupt Hippo signaling and thereby promote tumor cell proliferation, invasion, and drug resistance. Here, YAP1 is linked to head and neck squamous cell carcinoma.